Have your own idea? Try our Stock Screener
UPDATED Feb 22, 2025
Discover U.S. Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
NCNO | US$32.06 | -6.4% | 7.5% | US$3.7b | US$42.13 | PS7.1x | E125.4% | n/a | Software | ||
TWI | US$8.79 | -0.8% | -37.8% | US$555.0m | US$12.67 | PB0.9x | E125.4% | 0% | Capital Goods | ||
SMTC | US$37.10 | -0.7% | 82.8% | US$3.2b | US$68.64 | PS3.8x | E125.3% | n/a | Semiconductors | ||
CHMI | US$3.68 | 3.4% | 4.2% | US$118.5m | US$4.00 | PB0.9x | E125.2% | 16.3% | Diversified Financials | ||
DTST | US$3.75 | -8.3% | -6.7% | US$26.3m | US$9.00 | PE164.1x | E125.2% | n/a | Software | ||
AZTA | US$44.75 | -1.5% | -29.4% | US$2.0b | US$60.40 | PS3.1x | E124.7% | 0% | Pharmaceuticals & Biotech | ||
EVOK | US$5.07 | -5.6% | -34.1% | US$10.5m | US$18.00 | PS1.2x | E124.7% | n/a | Pharmaceuticals & Biotech | ||
MATV | US$6.86 | -24.6% | -58.0% | US$372.7m | US$15.83 | PB0.4x | E124.6% | 5.8% | Materials | ||
OPRT | US$7.89 | 4.2% | 103.4% | US$285.1m | US$8.50 | PB0.8x | E124.5% | n/a | Diversified Financials | ||
TUYA | US$4.06 | 36.2% | 129.4% | US$2.4b | US$3.24 | PS8.5x | E124.4% | 1.3% | Software | ||
BRSP | US$6.05 | 1.3% | -11.5% | US$784.6m | US$7.38 | PS2.2x | E124.1% | 10.6% | Diversified Financials | ||
TBRG | US$28.26 | 0.3% | 208.2% | US$404.8m | US$22.80 | PS1.2x | E124.1% | 0% | Healthcare | ||
WGS | US$95.83 | 25.5% | 1,116.1% | US$2.6b | US$107.33 | PS8.6x | E124.0% | n/a | Healthcare | ||
AORT | US$28.26 | -6.0% | 39.4% | US$1.2b | US$33.17 | PS3.1x | E123.9% | 0% | Healthcare | ||
PLX | US$2.39 | -11.2% | 64.8% | US$176.0m | US$14.50 | PS3.9x | E123.8% | n/a | Pharmaceuticals & Biotech | ||
EEX | US$4.23 | -3.4% | -34.2% | US$858.6m | US$7.90 | PS2.2x | E123.7% | 1.4% | Media | ||
ZETA | US$20.73 | -11.7% | 101.3% | US$4.9b | US$36.92 | PS5.5x | E123.5% | n/a | Software | ||
ORGO | US$3.21 | -13.2% | -7.2% | US$403.6m | US$5.00 | PB1.4x | E123.4% | n/a | Pharmaceuticals & Biotech | ||
AREC | US$0.54 | -13.5% | -59.4% | US$41.5m | US$4.00 | PS103.9x | E123.4% | n/a | Energy | ||
MRM | US$0.85 | 6.3% | -85.8% | US$6.7m | US$5.01 | PE-9x | E122.9% | n/a | Consumer Services | ||
FNKO | US$13.51 | -0.5% | 90.8% | US$732.2m | US$11.50 | PB3x | E122.5% | n/a | Consumer Durables | ||
BTDR | US$13.09 | -20.7% | 102.0% | US$2.5b | US$25.93 | PS6.4x | E122.5% | n/a | Software | ||
ORN | US$7.07 | -10.5% | 7.8% | US$275.0m | US$11.67 | PB1.9x | E122.1% | n/a | Capital Goods | ||
CEVA | US$34.49 | -0.5% | 55.4% | US$814.9m | US$37.17 | PS7.6x | E122.1% | n/a | Semiconductors |